| Caption | Speech from Rogier Janssens, Managing Director and General Manager of Merck’s biopharma business in China |
| Source | Merck |
| Other pictures |
|
| Download | |
| Related Press Releases Links |
Merck Announces Collaboration with Xian Janssen to Launch INVOKANA(R) (canagliflozin) for the Treatment of Type 2 Diabetes in China 默克宣布与西安杨森合作在中国推出2型糖尿病治疗新型药物怡可安 |